DarioHealth Corp Valuation
| DRIO Stock | USD 11.03 0.40 3.50% |
At this time, the firm appears to be undervalued. DarioHealth Corp shows a prevailing Real Value of $13.91 per share. The current price of the firm is $11.03. Our model computes the value of DarioHealth Corp from reviewing the firm fundamentals such as Profit Margin of (1.71) %, shares outstanding of 6.76 M, and Current Valuation of 78.94 M as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting DarioHealth Corp's valuation include:
Price Book 1.057 | Enterprise Value | Enterprise Value Ebitda (0.59) | Price Sales 3.1234 | Forward PE 10.5932 |
Undervalued
Today
Please note that DarioHealth Corp's price fluctuation is somewhat reliable at this time. Calculation of the real value of DarioHealth Corp is based on 3 months time horizon. Increasing DarioHealth Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since DarioHealth Corp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of DarioHealth Stock. However, DarioHealth Corp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 11.03 | Real 13.91 | Target 18.0 | Hype 11.5 | Naive 12.68 |
The intrinsic value of DarioHealth Corp's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence DarioHealth Corp's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of DarioHealth Corp helps investors to forecast how DarioHealth stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of DarioHealth Corp more accurately as focusing exclusively on DarioHealth Corp's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use DarioHealth Corp's intrinsic value based on its ongoing forecasts of DarioHealth Corp's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against DarioHealth Corp's closest peers.
DarioHealth Corp Cash |
|
DarioHealth Corp Total Value Analysis
DarioHealth Corp is currently forecasted to have valuation of 78.94 M with market capitalization of 77.25 M, debt of 30.19 M, and cash on hands of 67.95 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the DarioHealth Corp fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
78.94 M | 77.25 M | 30.19 M | 67.95 M |
DarioHealth Corp Investor Information
About 23.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.06. Some equities with similar Price to Book (P/B) outperform the market in the long run. DarioHealth Corp recorded a loss per share of 11.14. The entity last dividend was issued on the 18th of November 2019. The firm had 1:20 split on the 28th of August 2025. Based on the analysis of DarioHealth Corp's profitability, liquidity, and operating efficiency, DarioHealth Corp may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.DarioHealth Corp Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. DarioHealth Corp has an asset utilization ratio of 22.74 percent. This suggests that the Company is making $0.23 for each dollar of assets. An increasing asset utilization means that DarioHealth Corp is more efficient with each dollar of assets it utilizes for everyday operations.DarioHealth Corp Profitability Analysis
Considering DarioHealth Corp's profitability and operating efficiency indicators, DarioHealth Corp may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess DarioHealth Corp's ability to earn profits and add value for shareholders.Net Loss | First Reported 2012-03-31 | Previous Quarter -13 M | Current Value -2.1 M | Quarterly Volatility 6.1 M |
For DarioHealth Corp profitability analysis, we use financial ratios and fundamental drivers that measure the ability of DarioHealth Corp to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well DarioHealth Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between DarioHealth Corp's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of DarioHealth Corp over time as well as its relative position and ranking within its peers.
DarioHealth Corp Earnings per Share Projection vs Actual
The next projected EPS of DarioHealth Corp is estimated to be -2.355 with future projections ranging from a low of -2.6 to a high of -2.11. DarioHealth Corp's most recent 12-month trailing earnings per share (EPS TTM) is at -11.14. Please be aware that the consensus of earnings estimates for DarioHealth Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.DarioHealth Corp Earnings Estimation Breakdown
The calculation of DarioHealth Corp's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of DarioHealth Corp is estimated to be -2.355 with the future projection ranging from a low of -2.6 to a high of -2.11. Please be aware that this consensus of annual earnings estimates for DarioHealth Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-2.6 Lowest | Expected EPS | -2.11 Highest |
DarioHealth Corp Earnings Projection Consensus
Suppose the current estimates of DarioHealth Corp's value are higher than the current market price of the DarioHealth Corp stock. In this case, investors may conclude that DarioHealth Corp is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and DarioHealth Corp's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2025 | Current EPS (TTM) | |
| 4 | 55.19% | -2.96 | -2.355 | -11.14 |
DarioHealth Corp Ownership Allocation
The market capitalization of DarioHealth Corp is $77.25 Million. DarioHealth Corp retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.DarioHealth Corp Profitability Analysis
The company reported the previous year's revenue of 27.04 M. Net Loss for the year was (42.75 M) with profit before overhead, payroll, taxes, and interest of 16.84 M.About DarioHealth Corp Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of DarioHealth Corp. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of DarioHealth Corp based exclusively on its fundamental and basic technical indicators. By analyzing DarioHealth Corp's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of DarioHealth Corp's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of DarioHealth Corp. We calculate exposure to DarioHealth Corp's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of DarioHealth Corp's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 15.3 M | 16 M | |
| Pretax Profit Margin | (1.48) | (1.56) | |
| Operating Profit Margin | (1.92) | (2.02) | |
| Net Loss | (1.42) | (1.49) | |
| Gross Profit Margin | 0.44 | 0.46 |
DarioHealth Corp Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 67.2 M | |
| Forward Price Earnings | 10.5932 |
DarioHealth Corp Current Valuation Indicators
DarioHealth Corp's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final DarioHealth Corp's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as DarioHealth Corp, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use DarioHealth Corp's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes DarioHealth Corp's worth.When determining whether DarioHealth Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DarioHealth Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dariohealth Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dariohealth Corp Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Will Health Care Technology sector continue expanding? Could DarioHealth diversify its offerings? Factors like these will boost the valuation of DarioHealth Corp. Projected growth potential of DarioHealth fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every DarioHealth Corp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (11.14) | Revenue Per Share | Quarterly Revenue Growth (0.33) | Return On Assets | Return On Equity |
DarioHealth Corp's market price often diverges from its book value, the accounting figure shown on DarioHealth's balance sheet. Smart investors calculate DarioHealth Corp's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since DarioHealth Corp's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between DarioHealth Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DarioHealth Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.